Nuria Quesada García (@nuria_quesada2) 's Twitter Profile
Nuria Quesada García

@nuria_quesada2

Iberia Marketing Manager at Abbott Vascular. All opinions are my own

ID: 764033945709207552

linkhttp://www.linkedin.com/in/nuriaquesadagarcia calendar_today12-08-2016 09:41:02

209 Tweet

164 Followers

506 Following

European Society of Cardiology (@escardio) 's Twitter Profile Photo

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided #PCI ⬇️ #ESCCongress ILUMIEN IV trial

Optical coherence tomography (OCT)-guided  percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce  the two-year rate of target vessel failure compared with angiography-guided #PCI ⬇️

#ESCCongress ILUMIEN IV trial
European Society of Cardiology (@escardio) 's Twitter Profile Photo

Percutaneous coronary intervention (#PCI) guided by optical coherence tomography (#OCT) reduces adverse cardiac events in patients with bifurcation lesions ⬇️ #ESCCongress OCTOBER trial

Percutaneous coronary intervention (#PCI) guided by optical coherence tomography (#OCT) reduces adverse cardiac events in patients with bifurcation lesions ⬇️

#ESCCongress OCTOBER trial
European Society of Cardiology (@escardio) 's Twitter Profile Photo

Optical coherence tomography (#OCT) is non-inferior to intravascular ultrasound (#IVUS) for guiding percutaneous coronary intervention (#PCI) ⬇️ #ESCCongress OCTIVUS trial

Optical coherence tomography (#OCT) is non-inferior to intravascular ultrasound (#IVUS) for guiding percutaneous coronary intervention (#PCI) ⬇️

#ESCCongress OCTIVUS trial
European Society of Cardiology (@escardio) 's Twitter Profile Photo

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided #PCI ⬇️ #ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis

Intravascular imaging-guided percutaneous coronary intervention (PCI) is  associated with a lower rate of target lesion failure compared with  angiography-guided #PCI ⬇️

#ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

It’s finally OCT-ober 🎃 our special time of the year to highlight 🔑 info about #OCTimaging 💡 for PCI guidance. This year there’s a lot of new of imaging data post #ESC2023. So let’s dive in, #CardioTwitter. ⬇️ Safety Info: bit.ly/OCT_ISI 🧵 1/8

It’s finally OCT-ober 🎃 our special time of the year to highlight 🔑 info about #OCTimaging 💡 for PCI guidance.

This year there’s a lot of new of imaging data post #ESC2023. So let’s dive in, #CardioTwitter. ⬇️ 

Safety Info: bit.ly/OCT_ISI
🧵 1/8
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

From the latest #OCTimaging clinical data at #ESC2023 to the latest imaging solution—Ultreon 2.0 Software, our AI-enabled IVI software. 3⃣top reasons why you should consider Ultreon Software for your complex PCI. #imagefirst Safety Info: bit.ly/3mHYQvh 1/5

From the latest #OCTimaging clinical data at #ESC2023 to the latest imaging solution—Ultreon 2.0 Software, our AI-enabled IVI software.

3⃣top reasons why you should consider Ultreon Software for your complex PCI.

#imagefirst

Safety Info: bit.ly/3mHYQvh

1/5
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

Get a demo of our latest Ultreon 2.0 Software for #OCTimaging at #TCT2023 at Abbott’s booth. ➡️ Sign up to get more info: bit.ly/46oyh1x #imagefirst Safety Info: bit.ly/3mHYQvh

Get a demo of our latest Ultreon 2.0 Software for #OCTimaging at #TCT2023 at Abbott’s booth. 

➡️ Sign up to get more info: bit.ly/46oyh1x

#imagefirst 

Safety Info: bit.ly/3mHYQvh
Antonio Gomez Menchero (@antoniogomezm21) 's Twitter Profile Photo

I curso de Calcio-OCT en HJRJ, Huelva. La formación, la base para abordar las lesiones coronarias mas complejas guiadas por OCT, buscando la excelencia con grandes AMIGOS EXPERTOS. Javier Suarez d Lezo @AJuradoRoman Santiago Jesús Camacho Freire Izaga Oscar Lagos Alba Abril Molina

I curso de Calcio-OCT en HJRJ, Huelva. La formación, la base para abordar las lesiones coronarias mas complejas guiadas por OCT, buscando la excelencia con grandes AMIGOS EXPERTOS. <a href="/cardiojsl/">Javier Suarez d Lezo</a> @AJuradoRoman <a href="/CamachoFreire/">Santiago Jesús Camacho Freire</a> <a href="/ElenaIzaga/">Izaga</a> <a href="/OscarLa81605851/">Oscar Lagos</a> <a href="/Albabfc/">Alba Abril Molina</a>
josep (@josepgomezlara) 's Twitter Profile Photo

Aun quedan plazas libres para asistir al curso de MINOCA el 2/2/24 en BCN. Expertos nacionales e internacionales nos mostraran los algoritmos diagnosticos para este dx de trabajo y sus causas con la presentacion de 6 casos clinicos. No te lo pierdas! Link: secardiologia.es/agenda/2877-ad…

HeartFlow (@heartflow) 's Twitter Profile Photo

Join us during ACI 2024 in London on 1/31 from 6-8pm at the Hilton Metropole London, UL. Discover the future of cardiac care with HeartFlow’s interactive session on CCTA+FFRCT at BCIS ACI 2024. Register here: bit.ly/3HvCVR4. Nick Curzen Carlos Collet MD PhD BCIS

Join us during ACI 2024 in London on 1/31 from 6-8pm at the Hilton Metropole London, UL. Discover the future of cardiac care with HeartFlow’s interactive session on CCTA+FFRCT at BCIS ACI 2024. Register here: bit.ly/3HvCVR4. 
<a href="/NickCurzen/">Nick Curzen</a> <a href="/ColletCarlos/">Carlos Collet MD PhD</a> <a href="/BCIS_uk/">BCIS</a>
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

Large network meta-analysis shared in The Lancet bit.ly/4bPbFuP showed for the first time reductions in clinical events demonstrating safety & effectiveness of image-guided PCI ⬇️25% all-cause death ⬇️17% MI ⬇️48% ST ⬇️28% repeat TVR Safety Info: bit.ly/ISI_info

Large network meta-analysis shared in <a href="/theLancet/">The Lancet</a> bit.ly/4bPbFuP showed for the first time reductions in clinical events demonstrating safety &amp; effectiveness of image-guided PCI
⬇️25% all-cause death
⬇️17% MI
⬇️48% ST
⬇️28% repeat TVR

Safety Info: bit.ly/ISI_info
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

📰 Late-breaking data at #CRT2024: XIENCE #Stent showed strong performance in patients with single-layer ISR at 1-year: ¹ • 0% cardiac death  • 0.4% all cause death  • 1.2% ST    Learn more & safety Info: cardiovascular.abbott/us/en/hcp/prod…

📰 Late-breaking data at #CRT2024: XIENCE #Stent showed strong performance in patients with single-layer ISR at 1-year: ¹
• 0% cardiac death 
• 0.4% all cause death 
• 1.2% ST 
 
Learn more &amp; safety Info: cardiovascular.abbott/us/en/hcp/prod…
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

Happening NOW in the #EuroPCR Training Village. Great to see physicians honing their skills with our AI-driven #IntravascularImaging and exploring the features of our orbital atherectomy technology. #CardioTwitter

Happening NOW in the #EuroPCR Training Village.

Great to see physicians honing their skills with our AI-driven #IntravascularImaging and exploring the features of our orbital atherectomy technology.

#CardioTwitter
Coroventis Research (@coroventis) 's Twitter Profile Photo

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B.

This represent a paradigm shift in the diagnosis and treatment of these patients.
Abbott Cardiovascular (@abbottcardio) 's Twitter Profile Photo

⚡️Big News w/ #ESCGuidelines OCT-guided PCI & assessing patients for CMD now @ Class 1A & 1B Abbott leads the way w/ unique solutions to improve patient outcomes AI-driven #Ultreon for OCT PressureWire X & CoroFlow for INOCA/ANOCA patients Safety Info: bit.ly/3T8XwRn